These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26449252)

  • 21. Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans.
    Fischer H; Huber V; Boknik P; Luess H; Neumann J; Schmitz W; Domschke W; Konturek JW
    Microsc Res Tech; 2001 Jun; 53(5):336-42. PubMed ID: 11376494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
    Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population.
    Liu F; Pan K; Zhang X; Zhang Y; Zhang L; Ma J; Dong C; Shen L; Li J; Deng D; Lin D; You W
    Gastroenterology; 2006 Jun; 130(7):1975-84. PubMed ID: 16762620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
    Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.
    Brzozowski T; Konturek PC; Mierzwa M; Drozdowicz D; Bielanski W; Kwiecien S; Konturek SJ; Stachura J; Pawlik WW; Hahn EG
    Helicobacter; 2006 Feb; 11(1):10-20. PubMed ID: 16423085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
    Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
    Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
    Mohar A; Ley C; Guarner J; Herrera-Goepfert R; Figueroa LS; Halperin D; Parsonnet J
    Am J Gastroenterol; 2002 Oct; 97(10):2530-5. PubMed ID: 12385434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
    Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Di Mario F; Malfertheiner P
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1225-33. PubMed ID: 16611284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells.
    Iwamoto J; Mizokami Y; Takahashi K; Matsuoka T; Matsuzaki Y
    Helicobacter; 2008 Jun; 13(3):174-82. PubMed ID: 18466392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups.
    Li WQ; Ma JL; Zhang L; Brown LM; Li JY; Shen L; Pan KF; Liu WD; Hu Y; Han ZX; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; You WC; Gail MH
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24925350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study.
    Zhou L; Lin S; Ding S; Huang X; Jin Z; Cui R; Meng L; Li Y; Zhang L; Guo C; Xue Y; Yan X; Zhang J
    Chin Med J (Engl); 2014; 127(8):1454-8. PubMed ID: 24762588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.
    Zhang S; Lee DS; Morrissey R; Aponte-Pieras JR; Rogers AB; Moss SF
    Cancer Lett; 2015 Apr; 359(2):345-51. PubMed ID: 25853150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cyclooxygenase-2 inhibition on human Helicobacter pylori gastritis: mechanisms underlying gastrointestinal safety and implications for cancer chemoprevention.
    Scheiman JM; Greenson JK; Lee J; Cryer B
    Aliment Pharmacol Ther; 2003 Jun; 17(12):1535-43. PubMed ID: 12823157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.
    Massarrat S; Haj-Sheykholeslami A; Mohamadkhani A; Zendehdel N; Rakhshani N; Stolte M; Mirzaei M; Saliminejhad M; Saeidi S; Shahidi M
    Arch Iran Med; 2012 Nov; 15(11):664-9. PubMed ID: 23102241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data.
    Gail MH; You WC; Chang YS; Zhang L; Blot WJ; Brown LM; Groves FD; Heinrich JP; Hu J; Jin ML; Li JY; Liu WD; Ma JL; Mark SD; Rabkin CS; Fraumeni JF; Xu GW
    Control Clin Trials; 1998 Aug; 19(4):352-69. PubMed ID: 9683311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population.
    Pan KF; Formichella L; Zhang L; Zhang Y; Ma JL; Li ZX; Liu C; Wang YM; Goettner G; Ulm K; Classen M; You WC; Gerhard M
    Int J Cancer; 2014 May; 134(9):2118-25. PubMed ID: 24155048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa].
    Unger Z; Prónai L; Szaleczky E; Zágoni T; Molnár B; Tulassay Z
    Orv Hetil; 2000 Dec; 141(50):2695-700. PubMed ID: 11189675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between RUNX3 expression and precancerous gastric lesions in high-risk population].
    Li WQ; Pan KF; Zhang Y; Zhang L; Ma JL; Zhou T; Li JY; Wang Z; Su Y; You WC
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 41(3):348-52. PubMed ID: 19727221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality.
    Ma JL; Zhang L; Brown LM; Li JY; Shen L; Pan KF; Liu WD; Hu Y; Han ZX; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; You WC; Gail MH
    J Natl Cancer Inst; 2012 Mar; 104(6):488-92. PubMed ID: 22271764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer.
    You WC; Zhang L; Gail MH; Ma JL; Chang YS; Blot WJ; Li JY; Zhao CL; Liu WD; Li HQ; Hu YR; Bravo JC; Correa P; Xu GW; Fraumeni JF
    Int J Epidemiol; 1998 Dec; 27(6):941-4. PubMed ID: 10024185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.